These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12126722)

  • 21. A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality.
    Eyer-Silva WA; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Dec; 100(8):869-73. PubMed ID: 16444418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand.
    Poonpiriya V; Sungkanuparph S; Leechanachai P; Pasomsub E; Watitpun C; Chunhakan S; Chantratita W
    J Virol Methods; 2008 Jul; 151(1):79-86. PubMed ID: 18462814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil.
    Toledo PV; Carvalho DS; Romagnoli L; Marcinko G; Cunha CA; Souza MN; Brindeiro R; Queiroz-Telles Fd
    Braz J Infect Dis; 2010; 14(4):360-71. PubMed ID: 20963321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic testing for human immunodeficiency virus type 1 drug resistance.
    Shafer RW
    Clin Microbiol Rev; 2002 Apr; 15(2):247-77. PubMed ID: 11932232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].
    Si XF; Huang HL; Wei M; Guan Q; Song YH; Ma PF; Quan Y; Xing H; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):308-11. PubMed ID: 15650776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of drug resistance assays in testing HIV-1 non-B subtypes.
    Holguín A; Hertogs K; Soriano V
    Clin Microbiol Infect; 2003 Apr; 9(4):323-6. PubMed ID: 12667245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.
    Kantor R; Zijenah LS; Shafer RW; Mutetwa S; Johnston E; Lloyd R; von Lieven A; Israelski D; Katzenstein DA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1407-13. PubMed ID: 12512512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor.
    Servais J; Hainaut M; Schmitz V; Maes P; Fransen K; Vaira D; Brichard B; Arendt V; Schneider F; Hemmer R; Schmit JC
    Pediatr Infect Dis J; 2002 Mar; 21(3):214-20. PubMed ID: 12005085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals.
    Simon V; Vanderhoeven J; Hurley A; Ramratnam B; Louie M; Dawson K; Parkin N; Boden D; Markowitz M
    AIDS; 2002 Jul; 16(11):1511-9. PubMed ID: 12131189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.
    Cabana M; Clotet B; Martínez MA
    J Med Virol; 1999 Dec; 59(4):480-90. PubMed ID: 10534730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.
    García-Lerma JG; Heneine W
    J Clin Virol; 2001 Jun; 21(3):197-212. PubMed ID: 11397656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.
    Kijak GH; Rubio AE; Pampuro SE; Zala C; Cahn P; Galli R; Montaner JS; Salomón H
    HIV Med; 2003 Jan; 4(1):72-8. PubMed ID: 12534963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.
    Kagan R; Winters M; Merigan T; Heseltine P
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):1-9. PubMed ID: 15000693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.
    Ross L; Liao Q; Gao H; Pham S; Tolson J; Hertogs K; Larder B; Saag MS
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1379-85. PubMed ID: 11679150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.
    Park SW; Kim HB; Choi YJ; Kim NJ; Oh MD; Choe KW
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):1039-43. PubMed ID: 14686324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals.
    Shafer RW; Warford A; Winters MA; Gonzales MJ
    J Virol Methods; 2000 May; 86(2):143-53. PubMed ID: 10785289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire.
    Bilé EC; Adjé-Touré C; Borget MY; Kalou M; Diomande F; Chorba T; Nkengasong JN
    J Clin Virol; 2005 Jan; 32(1):60-6. PubMed ID: 15572008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.